Artificial Intelligence in Medicine
Volume 37, Issue 1 , Pages 65-71 , May 2006

Statistical analysis of combined dose effects for experiments with two agents

  • Stefan Wagenpfeil

      Affiliations

    • Institut für Medizinische Statistik und Epidemiologie der Technischen Universität München, Klinikum rechts der Isar, Ismaninger Str. 22, D-81675 München, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 8941404350; fax: +49 8941404973.
    web address
    • ,
  • Uwe Treiber

      Affiliations

    • Urologische Klinik und Poliklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaninger Str. 22, D-81675 München, Germany
    • ,
  • Antonie Lehmer

      Affiliations

    • Urologische Klinik und Poliklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaninger Str. 22, D-81675 München, Germany

Received 19 July 2004 ,Revised 17 January 2005 ,Accepted 20 January 2005.

References 

  1. Wagenpfeil S, Treiber U, Lehmer A. A MATLAB-based software tool for changepoint detection and nonlinear regression in dose–response relationships. In:  Brause RW,  Hanisch E editor. Medical data analysis, lecture notes in computer science. vol. 1993:Berlin: Springer-Verlag; 2000;p. 190–197
  2. Röhm NW, Rodgers GH, Hatfield SM, Glasebook AL. Unimproved colorimetric assay for cell proliferation and viability utilizing tetrazoliumsalt XTT. J Immunol Methods. 1991;142:257–265
  3. Wagenpfeil S, Treiber U, Lehmer A. Isobologram analysis in MATLAB for combined effects of two agents in dose–response experiments. In:  Perner P,  Brause R,  Holzhütter H-G editor. Medical data analysis, lecture notes in computer science. vol. 2868:Berlin, Heidelberg, New York: Springer-Verlag; 2003;p. 47–54
  4. Chuang-Stein C, Agresti A. Tutorial in biostatistics: a review of tests for detecting a monotone dose–response relationship with ordinal response data. Stat Med. 1997;16:2599–2618
  5. Steel GG, Peckham MJ. Exploitable mechanisms in combined radiotherapy–chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Physiol. 1979;5:85–91
  6. Kano Y, Suzuki K, Akutsu M, Suda K, Inoue Y, Yoshida M,, et al. Effects of CPT-11 in combination with other anti-cancer agents in culture. Int J Cancer. 1992;50:604–610
  7. Chou TC, Talalay P. Quantitative analysis of dose–effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55
  8. Holstein SA, Hohl RJ. Synergistic interaction of lovastatin and paclitaxel in human cancer cells. Mol Cancer Ther. 2001;1:141–149
  9. Figul M, Söling A, Dong HJ, Chou TC, Rainov NG. Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells. Cancer Chemother Pharmacol. 2003;52:41–46
  10. Tallarida RJ. The interaction index: a measure of drug synergism. Pain. 2002;98:163–168
  11. Avramis IA, Laug WE, Sausville EA, Avramis VI. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines. Cancer Chemother Pharmacol. 2003;52:307–318
  12. Meco D, Colombo T, Ubezio P, Zucchetti M, Zaffaroni M, Riccardi A,, et al. Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies. Cancer Chemother Pharmacol. 2003;52:131–138
  13. Kenett R, Zacks S. Modern industrial statistics—the design and control of quality and reliability. Pacific Grove, CA, USA: Duxbury Press; 1998;
  14. Wu CFJ. Efficient sequential designs with binary data. J Am Stat Assoc. 1985;80:974–984
  15. Sitter RR, Forbes BE. Optimal two-stage designs for binary response experiments. Stat Sinica. 1997;7:941–955
  16. O’Brien WD, Simpson DG, Frizzell LA, Zachary JF. Superthreshold behavior and threshold estimates of ultrasound-induced lung hemorrhage in adult rats: role of beamwidth. IEEE Trans Ultrason, Ferroelectr Frequency Control. 2001;48:1695–1705
  17. Clyde M, Mueller P, Parmigiani G. Optimal design for heart defibrillators. In:  Gatsonis C,  Hodges JS,  Kass RE,  Singpurwalla ND editor. Bayesian statistics in science and engineering: case studies II. Berlin: Springer-Verlag; 1995;p. 278–292
  18. Dette H, Neumeyer N, Pilz KF. A note on nonparametric estimation of the effective dose in quantal bioassay. Technical Report, Ruhr-Universität-Bochum. http://www.ruhr-uni-bochum.de/mathematik3/preprint.htm; 2003 (last accessed: 17 January 2005).
  19. Biedermann S, Dette H, Zhu W. Optimal designs for dose–response models with restricted design spaces. Technical Report, Ruhr-Universität-Bochum. http://www.ruhr-uni-bochum.de/mathematik3/preprint.htm; 2004 (last accessed: 17 January 2005).
  20. Nishizaki M, Meyn RE, Levy LB, Atkinson EN, White RA, Roth JA,, et al. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Clin Cancer Res. 2001;7:2887–2897
  21. Kano Y, Akutsu M, Suzuki K, Mori K, Yazawa Y, Tsunoda S. Schedule-dependent interactions between paclitaxel and etoposide in human carcinoma cell lines in vitro. Cancer Chemother Pharmacol. 1999;44:381–388
  22. Menendez JA, Ropero S, del Barbacid MM, Montero S, Solanas M, Escrich E,, et al. Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells. Breast Cancer Res Treat. 2002;72:203–219
  23. Tan YJ, Teng E, Ting AE. A small inhibitor of the interaction between Bax and Bcl-X(L) can synergize with methylprednisolone to induce apoptosis in Bcl-X(L)-overexpressing breast-cancer cells. J Cancer Res Clin Oncol. 2003;129:437–448
  24. Vasilevskaya IA, Rakitina TV, O’Dwyer PJ. Geldanamycin and its 17-allylamino-17-demethoxy analogue antagonize the action of cisplatin in human colon adenocarcinoma cells: differential caspase activation as a basis for interaction. Cancer Res. 2003;63:3241–3246
  25. Shingu T, Yamada K, Hara N, Moritake K, Osago H, Terashima M,, et al. Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells. Cancer Res. 2003;63:4044–4047
  26. Coleman Th, Branch MA, Grace A. optimization toolbox for use with MATLAB, user’s guide, Version 2. 3rd printing, Natick, MA 01760–1500, USA: The Math Works Inc.; 1999.
  27. Luszczki JJ, Czuczwar SJ. Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics-a comparative study. Epilepsy Res. 2003;56:27–42

PII: S0933-3657(05)00088-6

doi: 10.1016/j.artmed.2005.01.011

Artificial Intelligence in Medicine
Volume 37, Issue 1 , Pages 65-71 , May 2006

Article Tools

* Image Usage & Resolution